Pharmahungary Group as a Hungarian SME is ready to join Horizon Europe grant applications with innovative preclinical and clinical R&D services.
Pharmahungary Group joins COST Action titled „Realising the therapeutic potential of novel cardioprotective therapies”.
Pharmahungary Group scientific management will attend the 34th Annual Meeting of the European Section of the ISHR in Hamburg, Germany, July 24-27.
Pharmahungary Group Clinical Director Eszter Fodor, MD will attend the 7th PHARM Connect Congress.
Pharmahungary Group Founder & CEO will hold scientific presentations at European Society of Cardiology Congress.